194 related articles for article (PubMed ID: 18616622)
1. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.
Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T
Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622
[TBL] [Abstract][Full Text] [Related]
2. New pharmacotherapies for pediatric seizures.
Pellock JM
Pediatr Ann; 2004 Jun; 33(6):385-91. PubMed ID: 19449513
[No Abstract] [Full Text] [Related]
3. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
[TBL] [Abstract][Full Text] [Related]
4. Refractory epilepsy: treatment with new antiepileptic drugs.
Datta PK; Crawford PM
Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
[TBL] [Abstract][Full Text] [Related]
5. New antiepileptic drugs in pediatric epilepsy.
Hwang H; Kim KJ
Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of new antiepileptic drugs.
Gram L
Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037
[TBL] [Abstract][Full Text] [Related]
7. Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.
Carpay JA; Aalbers K; Graveland GA; Engelsman M
Seizure; 2009 Mar; 18(2):119-23. PubMed ID: 18760635
[TBL] [Abstract][Full Text] [Related]
8. Novel anticonvulsant drugs.
Stefan H; Feuerstein TJ
Pharmacol Ther; 2007 Jan; 113(1):165-83. PubMed ID: 17030393
[TBL] [Abstract][Full Text] [Related]
9. Effects of antiepileptic drugs on cognition.
Aldenkamp AP
Epilepsia; 2001; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Johannessen SI; Tomson T
Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
[TBL] [Abstract][Full Text] [Related]
11. New antiepileptic drugs: a systematic review of their efficacy and tolerability.
Marson AG; Kadir ZA; Chadwick DW
BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746
[TBL] [Abstract][Full Text] [Related]
12. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
Perucca E; Johannessen SI
Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
[TBL] [Abstract][Full Text] [Related]
13. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
14. The clinical pharmacokinetics of the new antiepileptic drugs.
Perucca E
Epilepsia; 1999; 40 Suppl 9():S7-13. PubMed ID: 10612356
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic drugs in migraine prophylaxis: state of the art.
Capuano A; Vollono C; Mei D; Pierguidi L; Ferraro D; Di Trapani G
Clin Ter; 2004; 155(2-3):79-87. PubMed ID: 15244112
[TBL] [Abstract][Full Text] [Related]
19. New antiepileptic drugs in practice--how do they perform in the real world?
Sander JW
Acta Neurol Scand Suppl; 2005; 181():26-9. PubMed ID: 16238705
[TBL] [Abstract][Full Text] [Related]
20. New antiepileptic drug therapies.
Bergin AM; Connolly M
Neurol Clin; 2002 Nov; 20(4):1163-82. PubMed ID: 12616686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
